Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120

Journal of Neurochemistry

Volumn 104, Issue 6, 2008, Pages 1478-1493

  Singh, Ashok K ^a   Gupta, Shveta ^a   Jiang, Yin ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Ethanol; Human immunodeficiency virus envelop protein gp120; Oxidative stress; Peroxiredoxin I; Protein carbonylation

Indexed keywords

ACETALDEHYDE; CYSTEINE; GLYCOPROTEIN GP 120; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PEROXIREDOXIN; PEROXIREDOXIN 1; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; UNCLASSIFIED DRUG;

ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; FLUID INTAKE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT;

ACETALDEHYDE; ALCOHOL DRINKING; ANIMALS; ASPARTIC ACID; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DIPEPTIDES; DRINKING; ETHANOL; FREE RADICALS; HIV ENVELOPE PROTEIN GP120; ISOTONIC SOLUTIONS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEINS; RATS; SODIUM CHLORIDE; SULFHYDRYL COMPOUNDS;

HUMAN IMMUNODEFICIENCY VIRUS; RATTUS;

EID: 39849090031     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05094.x     Document Type: Article

References (118)

1. Aksenov M. Y., Hasselrot U., Bansal A. K., Wu G., Nath A., Anderson C., Mactutus C. F. and Booze R. M. (2001) Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci. Lett. 305, 5-8.
2. Aksenov M. Y., Hasselrot U., Wu G., Nath A., Anderson C., Mactutus C. F. and Booze R. M. (2003) Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res. 987, 1-9.
3. Albano E. (2006) Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65, 278-790.
4. Alvarez S., Jimenez J. L., Serramia M. J., Gonzalez M., Canto-Nogues C. and Munoz-Fernandez M. A. (2006) Lack of association of HIV-1 biological or molecular properties with neurotropism for brain cells. J. Mol. Neurosci. 29, 131-144.
5. Ances B. M. and Ellis R. J. (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Sem. Neurol. 27, 86-92.
6. Arana D. M., Alonso-Monge R., Du C., Calderone R. and Pla J. (2007) Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans. Cell. Microbiol. 9, 1647-1659.
7. Bachis A., Major E. O. and Mocchetti I. (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J. Neurosci. 23, 5715-5722.
8. Bae J. Y., Ahn S. J., Han W. and Noh D. Y. (2007) Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines. J. Cell. Biochem. 101, 1038-1045.
9. Banday A. A., Fazili F. R. and Lokhandwala M. F. (2007) Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factorkappaB and protein kinase C. J. Am. Soc. Nephrol. 18, 1446-1457.
10. Banks W. A., Ercal N. and Price T. O. (2006) The blood-brain barrier in neuroAIDS. Curr. HIV Res. 4, 259-266.
11. Battistuta J., Bjartmar C. and Trapp B. D. (2001) Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions. Neurochem. Res. 26, 695-702.
12. Belmadani A., Neafsey E. J. and Collins M. A. (2003) Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations. J. Neurovirol. 9, 45-54.
13. Belmadani A., Kumar S., Schipma M., Collins M. A. and Neafsey E. J. (2004) Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 15, 2093-2096.
14. Benlhabib E., Baker J. I., Keyler D. E. and Singh A. K. (2004) Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J. Med. Food 7, 168-179.
15. Bergeron R., Coyle J. T., Tsai G. and Greene R. W. (2005) NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 30, 7-16.
16. Bergeron R., Imamura Y., Frangioni J. V., Greene R. W. and Coyle J. T. (2007) Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus. J. Neurochem. 100, 346-357.
17. Bischofberger J. and Schild D. (1996) Glutamate and N- acetylaspartyglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptor. J. Neurophysiol. 76, 2089-2092.
18. Bozonet S. M., Findlay V. J., Day A. M., Cameron J., Veal E. A. and Morgan B. A. (2005) Oxidation of a eukaryotic 2-Cys peroxiredoxin is a molecular switch controlling the transcriptional response to increasing levels of hydrogen peroxide. J. Biol. Chem. 280, 23319-23327.
19. Brabers N. A. and Nottet H. S. (2006) Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur. J. Clin. Invest. 36, 447-458.
20. Brooke S., Chan R., Howard S. and Sapolsky R. (1997) Endocrine modulation of the neurotoxicity of gp120: implications for AIDSrelated dementia complex. Proc. Natl Acad. Sci. USA 94, 9457-9462.
21. Butterfield D. A., Koppal T., Howard B. et al. (1998) Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tertbutyl-alpha-phenylnitrone and vitamin E. Ann. NYAcad. Sci. 854, 448-462.
22. Campos S. C., Moreira D. A., Nunes T. D., Colepicolo P. and Brigagao M. R. (2005) Oxidative stress in alcohol-induced rat parotid sialadenosis. Arch. Oral Biol. 50, 661-668.
23. Chen Y., Davis-Gorman G., Watson R. R. and McDonagh P. F. (2002) Ethanol modulates coronary permeability to macromolecules in murine AIDS. Alc. Alc. 37, 555-560.
24. Chevallet M., Wagner E., Luche S., van Dorsselaer A., Leize-Wagner E. and Rabilloud T. (2003) Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress. J. Biol. Chem. 278, 37146-37153.
25. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lint S., Glodberg M. P. and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-d-aspartate. J. Neurosci. 15, 6377-6388.
26. Dykens J. A. (1994) Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration. J. Neurochem. 63, 584-591.
27. Garden G. A. and Morrison R. S. (2005) The multiple roles of p53 in the pathogenesis of HIV associated dementia. Biochem. Biophys. Res. Commun. 331, 799-809.
28. Ghafouri M., Amini S., Khalili K. and Sawaya B. E. (2006) HIV-1 associated dementia: symptoms and causes. Retrovirology 3, 28-31.
29. Giancola M. L., Lorenzini P., Balestra P., Larussa D., Baldini F., Corpolongo A., Narciso P., Bellagamba R., Tozzi V. and Antinori A. (2006) Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 41, 332-337.
30. Giunta B., Obregon D., Hou H., Zeng J., Sun N., Nikolic V., Ehrhart J., Shytle D., Fernandez F. and Tan J. (2006) EPCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res. 1123, 216-225.
31. Goumon Y., Angelone T., Schoentgen F. et al. (2004) The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J. Biol. Chem. 279, 3054-3064.
32. Heales S. J., Davies S. E., Bates T. E. and Clark J. B. (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem. Res. 20, 31-38.
33. Husain K. (2007) Vascular endothelial oxidative stress in alcoholinduced hypertension. Cell. Mol. Biol. 53, 70-77.
34. Iakovlev A. A. and Guliaeva N. V. (2004) Using thioGlo-1 for the determination of thiols in brain tissue. Biomed. Khimiia. 50, 390-397.
35. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., Utsumi H., Machida Y., Epashira K. and Takeshita A. (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157.
36. Iwase T., Ojika K., Matsukawa N., Nishino H., Yamamoto T., Okada H., Fujimori O. and Ueda R. (2001) Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus. Neuroscience 102, 341-352.
37. Jana A. and Pahan K. (2004) Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redoxregulated activation of neutral sphingomyelinase. J. Neurosci. 24, 9531-9540.
38. Janssen R. S., Nwanyanwu O. C., Selik R. M. and Stehr-Green J. K. (1992) Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42, 1472-1476.
39. Jia Y. T., Ma B., Wei W., Xu Y., Wang Y., Tang H. T. and Xia Z. F. (2007) Sustained activation of nuclear factor-kappaB by reactive oxygen species is involved in the pathogenesis of stress-induced gastric damage in rats. Crit. Care Med. 35, 1582-1591.
40. Jones G. and Power C. (2006) Regulation of neural cell survival by HIV- 1 infection. Neurobiol. Dis. 21, 1-17.
41. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C. and Rhee S. G. (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J. Biol. Chem. 273, 6297-6302.
42. Kang K. A., Lee K. H., Zhang R., Piao M. J., Kang M. Y., Kwak Y. S., Yoo B. S., You H. J. and Hyun J. W. (2007) Protective effects of Castanopsis cuspidate through activation of ERK and NF-kappaB on oxidative cell death induced by hydrogen peroxide. J. Toxicol. Environ. Health Part A 70, 1319-1328.
43. Kao C. H., Kao T. Y., Huang W. T. and Lin M. T. (2007) Lipopolysaccharide- and glutamate-induced hypothalamic hydroxyl radical elevation and fever can be suppressed by N-methyl-D-aspartatereceptor antagonists. J. Pharm. Sci. 104, 130-136.
44. Kapaki E., Liappas I., Lyras L., Paraskevas G. P., Mamali I., Theotoka I., Bourboulis N., Liosis I., Petropoulou O. and Soldatos K. (2007) Oxidative damage to plasma proteins in patients with chronic alcohol dependence: the effect of smoking. In Vivo 21, 523-528.
45. Kaul M. and Lipton S. A. (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4, 307-318.
46. Kefaloyianni E., Gaitanaki C. and Beis I. (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell. Signal. 18, 2238-2251.
47. Kim H., Lee T. H., Park E. S., Suh J. M., Park S. J., Chung H. K., Kwon O. Y., Kim Y. K., Ro H. K. and Shong M. (2000) Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J. Biol. Chem. 275, 18266-18270.
48. Kim B. J., Hood B. L., Aragon R. A., Hardwick J. P., Conrads T. P., Veenstra T. D. and Song B. J. (2006) Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells. Proteomics 6, 1250-1260.
49. King J. E., Eugenin E. A., Buckner C. M. and Berman J. W. (2006) HIV tat and neurotoxicity. Microbes Infect. 8, 1347-1357.
50. Kono H., Rusyn I., Yin M. et al. (2000) NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106, 867-872.
51. Krakstad C., Christensen A. E. and Doskeland S. O. (2004) cAMP protects neutrophils against TNF-alpha-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). J. Leukoc. Biol. 76, 641-647.
52. Lachgar A., Sojic N., Arbault S., Bruce D., Sarasin A., Amatore C., Bizzini B., Zagury D. and Vuillaume M. (1999) Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive Tat and gp160 proteins. J. Virol. 73, 1447-1452.
53. LeBell C. P., Ischiropoulos H. and Bondy S. C. (1992) Evaluation of the probe 2¢,7¢-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227-231.
54. Lee C. K., Kim H. J., Lee Y. R., So H. H., Park H. J., Won K. J., Park T., Lee K. Y., Lee H. M. and Kim B. (2007) Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle. Biochem. Biophys. Acta 1774, 848-855.
55. Lenz A. G., Costabel U., Shaltiel S. and Levine R. L. (1989) Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal. Biochem. 177, 419-425.
56. Levi G., Patrizio M., Bernardo A., Petrucci T. C. and Agresti C. (1993) Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc. Natl Acad. Sci. USA 90, 1541-1545.
57. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S. and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478.
58. Li X. and Minden A. (2005) PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. J. Biol. Chem. 280, 41192-41200.
59. Li Y. and Wang H. (2004) In utero exposure to tobacco and alcohol modifies neurobehavioral development in mice offspring: consideration a role of oxidative stress. Pharmacol. Res. 49, 467-473.
60. Li W., Galey D., Mattson M. P. and Nath A. (2005) Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox. Res. 8, 119-134.
61. Li H. Y., Wu S. Y. and Shi N. (2007) Transcription factor Nrf2 activation by deltamethrin in PC12 cells: involvement of ROS. Toxicol. Lett. 171, 87-98.
62. Lipton S. A. (1996) Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol. 6, 507-517.
63. Lipton S. A., Yeh M. and Dreyer E. B. (1994) Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv. Neuroimmunol. 4, 181-188.
64. Liu S-X., Kawai K., TyurinV. A., TyurinaY. Y., Borisenko G. G., Fabisiak J. P., Pitt B. R. and Kagan V. E. (2001) Nitric oxide-dependent pro-oxidant and pro-apoptotic effect of metallothioneins in HL-60 cells challenged with cupric nitrilotriacetate. Biochem. J. 354, 397-406.
65. Maher P. (2006) Redox control of neural function: background, mechanisms, and significance. Antioxid. Redox Signal. 8, 1941-1970.
66. Mandal D., Moitra P. K., Saha S. and Basu J. (2002) Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett. 513, 184-188.
67. Masci A. M., Galgani M., Cassano S., De Simone S., Gallo A., De Rosa V., Zappacosta S. and Racioppi L. (2003) HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling. J. Leukoc. Biol. 74, 1117-1124.
68. Mattson M. P., Haughey N. J. and Nath A. (2005) Cell death in HIV dementia. Cell Death Differ. 12(Suppl. 1), 893-904.
69. Mizusawa H., Ishii T. and Bannai S. (2000) Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci. Lett. 283, 57-60.
70. Monden Y., Kubota T., Inoue T., Tsutsumi T., Kawano S., Ide T., Tsutsui H. and Sunagawa K. (2007) Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am. J. Physiol. 293, H743-H753.
71. Moon J. C., Hah Y. S., Kim W. Y. et al. (2005) Oxidative stressdependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J. Biol. Chem. 280, 8775-8784.
72. Mori H., Oikawa M., Tamagami T., Kumaki H., Nakaune R., Amano J., Akinaga Y., Fukui K., Abe K. and Urano S. (2007) Oxidized proteins in astrocytes generated in a hyperbaric atmosphere induce neuronal apoptosis. J. Alzheimer Dis. 11, 165-174.
73. Morin B., Bubb W. A., Davies M. J., Dean R. T. and Fu S. (1998) 3-Hydroxylysine, a potential marker for studying radical-induced protein oxidation. Chem. Res. Toxicol. 11, 1265-1273.
74. Nabeshi H., Oikawa S., Inoue S., Nishino K. and Kawanishi S. (2006) Proteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice. Free Radic. Res. 40, 1173-1181.
75. Nath A., Hauser K. F., Wojna V., Booze R. M., Maragos W., Prendergast M., Cass W. and Turchan J. T. (2002) Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2), S62-S69.
76. Nosheny R. L., Mocchetti I. and Bachis A. (2005) Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox. Res. 8, 187-198.
77. Odabaei G., Chatterjee D., Jazirehi A. R., Goodglick L., Yeung K. and Bonavida B. (2004) Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv. Cancer Res. 91, 169-200.
78. Ogura M., Taniura H., Nakamichi N. and Yoneda Y. (2007) Upregulation of the glutamine transporter through transactivation mediated by cAMP/protein kinase A signals toward exacerbation of vulnerability to oxidative stress in rat neocortical astrocytes. J. Cel. Physiol. 212, 375-385.
79. Oktyabrsky O. N. and Smirnova G. V. (2007) Redox regulation of cellular functions. Biochem. Russ. 72, 132-345.
80. Oliver C. N., Ahn B., Moerman E. J., Goldstein S. and Stadtman E. R. (1987) Age-related changes in oxidized proteins, J. Biol. Chem. 262, 5488-5491.
81. Opii W. O., Sultana R., Abdul H. M., Ansari M. A., Nath A. and Butterfield D. A. (2007) Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI) - 2¢,3¢-dideoxycytidine (ddC): relevance to HIV-dementia. Exp. Neurol. 204, 29-38.
82. Pehar M., Vargas M. R., Robinson K. M., Cassina P., Diaz-Amarilla P. J., Hagen T. M., Radi R., Barbeito L. and Beckman J. S. (2007) Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. J. Neurosci. 27, 7777-7785.
83. Poikolainen K., Vartiainen E. and Korhonen H. J. (1996) Alcohol intake and subjective health. Am. J. Epidemiol. 144, 346-350.
84. Price T. O., Ercal N., Nakaoke R. and Banks W. A. (2005) HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045, 57-63.
85. Rigamonti C., Mottaran E., Reale E., Rolla R., Cipriani V., Capelli F., Boldorini R., Vidali M., Sartori M. and Albano E. (2003) Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 38, 42-49.
86. Rossi A. G., Cousin J. M., Dransfield I., Lawson M. F., Chilvers E. R. and Haslett C. (1995) Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Comm. 217, 892-899.
87. Rubin Y., LaPlaca M. C., Smith D. H., Thibault L. E. and Lenkinski R. E. (1995) The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons. Neurosci. Lett. 198, 209-212.
88. Saha R. N. and Pahan K. (2007) Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: implications for HIV-associated dementia. Free Radic. Biol. Med. 42, 1866-1878.
89. Sanabria E. R., Wozniak K. M., Slusher B. S. and Keller A. (2004) GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism. J. Neurophysiol. 91, 182-193.
90. Sayed A. A., Cook S. K. and Williams D. L. (2006) Redox balance mechanisms in Schistosoma mansoni rely on peroxiredoxins and albumin and implicate peroxiredoxins as novel drug targets. J. Biol. Chem. 281, 17001-17010.
91. Schwartz L. and Major E. O. (2006) Neural progenitors and HIV-1-associated central nervous system disease in adults and children. Curr. HIV Res. 4, 319-327.
92. Sevier C. S. and Kaiser C. A. (2006) Conservation and diversity of the cellular disulfide bond formation pathways. Antioxid. Redox Signal. 8, 797-811.
93. Shiu C., Barbier E., Cello F. D., Choi H. J. and Stins M. (2007) HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alc. Clin. Exp. Res. 31, 130-137.
94. Singh A. and Gupta S. (2007) Analysis of recombinant human erythropoietin and darbepoietin in spiked plasma. Proteomics - Clin. Appl. 1, 626-639.
95. Singh A. K., Jiang Y., Benlhabib E. and Gupta S. (2007a) Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in E rats receiving free choice water and 15% ethanol in pure water. J. Med. Food 10, 526-542.
96. Singh A. K., Jiang Y. and Gupta S. (2007b) Effects of chronic alcohol drinking on receptor-binding, internalization and degradation of HIV-1 envelop protein gp120 in hepatocytes. Alcohol (In press).
97. Singh A. K., Jiang Y., Gupta S. and Benlhabib E. (2007c) Effects of chronic ethanol drinking on the blood-brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intra-peritoneal LPS injection. Alc. Alc. 42, 385-399.
98. Singhal P. C., Sagar S., Chandra D. and Garg P. (1995) Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity. Am. J. Pathol. 147, 25-32.
99. Steiner J., Haughey N., Li W., Venkatesan A., Anderson C., Reid R., Malpica T., Pocernich C., Butterfield D. A. and Nath A. (2006) Oxidative stress and therapeutic approaches in HIV dementia. Antioxid. Redox Signal. 8, 2089-2100.
100. Sui Z., Sniderhan L. F., Schifitto G., Phipps R. P., Gelbard H. A., Dewhurst S. and Maggirwar S. B. (2007) Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J. Immunol. 178, 3226-3236.
101. Sun H., Zheng H., Molacek E., Fang Q., Patel K. P. and Mayhan W. G. (2006) Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 37, 495-500.
102. Tohdoh N., Tojo S., Agui H. and Ojika K. (1995) Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine- binding protein and rat 23-kDa protein associated with the opioid-binding protein. Mol. Brain Res. 30, 381-384.
103. Tounai H., Hayakawa N., Kato H. and Araki T. (2007) Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin. Metab. Brain Dis. 22, 89-104.
104. Tozzi V., Balestra P., Serraino D. et al. (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res. Human Retro. 21, 706-713.
105. Tozzi V., Balestra P., Bellagamba R. et al. (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J. Acquir. Immune Defic. Syndr. 45, 174-182.
106. Tsai S. J. (2005) Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia. Med. Sci. Monitor. 11, HY39-HY45.
107. Uchida K. (2003) Histidine and lysine as targets of oxidative modification. Amino Acids 25, 247-257.
108. Vivancos A. P., Castillo E. A., Biteau B., Nicot C., Ayte J., Toledano M. B. and Hidalgo E. (2006) A cysteine-sulfinic acid in peroxiredoxin regulates H2O2-sensing by the antioxidant Pap1 pathway. Proc. Natl Acad. Sci. USA 102, 8875-8880.
109. Viviani B., Corsini E., Binaglia M., Galli C. L. and Marinovich M. (2001) Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience 107, 51-58.
110. Wagner E., Luche S., Penna L., Chevallet M., Van Dorsselaer A., Leize-Wagner E. and Rabilloud T. (2002) A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 366, 777-785.
111. Wang J., Yin D. P., Liu Y. X., Baer R. and Yin Y. (2007a) Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress. Cancer Res. 67, 6737-6744.
112. Wang J., Fields J., Zhao C., Langer J., Thimmulappa R. K., Kensler T. W., Yamamoto M., Biswal S. and Dore S. (2007b) Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic. Biol. Med. 43, 408-414.
113. Wood Z. A., Schroder E., Harris J. R. and Poole L. B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40.
114. Wroblewska B., Wroblewski J. T., Pshenichkin S., Surin A., Sullivan S. E. and Neale J. H. (1997) N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69, 174-181.
115. Wu D. and Cederbaum A. I. (2003) Alcohol, oxidative stress, and free radical damage. J. Natl Inst. Alc. Abuse Alc. 27, 277-284.
116. Yang K. S., Kang S. W., Woo H. A., Hwang S. C., Chae H. Z., Kim K. and Rhee S. G. (2002) Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277, 38029-38036.
117. Yeung K., Seitz T., Li S. et al. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177.
118. Yi Y., Lee C., Liu Q. H., Freedman B. D. and Collman R. G. (2004) Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: implications for neuropathogenesis. J. Neurovirol. 10(Suppl. 1), 91-96.